Autoradiographic localization of beta-adrenergic receptors in human large coronary arteries. 1991

F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
Dipartimento di Sanitá Pubblica e Biologia Cellulare, Universitá Tor Vergata, Rome, Italy.

The distribution of beta-adrenergic receptors in sections of the human right and left coronary arteries and of the anterior intraventricular branch was studied by the use of combined in vitro radioreceptor binding and autoradiographic techniques. [125I]Cyanopindolol was used as a ligand for beta-adrenergic receptors. Binding of the radioligand to sections of the three coronary arteries under study was saturable, stereoselective, reversible, and displaceable by antagonists and agonists with the rank order of potency expected for beta-adrenergic receptors. Analysis of binding isotherms indicated maximum binding capacities of 41.5 fmol/mg protein for the right coronary artery, 35.4 fmol/mg protein for the left coronary artery, and 25.7 fmol/mg protein for the anterior interventricular branch. Dissociation constants were approximately 35 pM in the arteries examined. The relative amounts of beta 1- and beta 2-receptor subtypes were as follows: 72% beta 1-receptors and 28% beta 2-receptors in the right coronary artery; 65% beta 1-receptors and 35% beta 2-receptors in the left coronary artery; 40% beta 1-receptors and 60% beta 2-receptors in the anterior interventricular branch. The results of autoradiographic analysis revealed a predominance of beta 1-receptors in the medial layer. beta 2-Receptors were localized primarily in the adventitia, in the adventitia-media border, and in the intimal layer. These results should lead to a better understanding of the mechanisms involved in the control of coronary circulation in humans.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
May 1987, Investigative ophthalmology & visual science,
F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
August 1987, Investigative ophthalmology & visual science,
F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
November 1988, Molecular and cellular endocrinology,
F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
November 1986, Brain research bulletin,
F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
October 1985, Neuroendocrinology,
F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
October 1986, Circulation research,
F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
October 1972, The American journal of physiology,
F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
February 1967, Annals of the New York Academy of Sciences,
F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
February 1984, The American journal of physiology,
F Amenta, and L Coppola, and P Gallo, and F Ferrante, and A Forlani, and A Monopoli, and P Napoleone
December 1992, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!